Table 1.
Patient Characteristics
| Variable | Neostigmine (n = 47) | Sugammadex (n = 46) | P value |
|---|---|---|---|
| Age (yr) | 65.5 ± 8.6 | 63.8 ± 9.7 | 0.378 |
| Sex (M/F) | 25/22 | 30/16 | 0.238 |
| Weight (kg) | 62.7 ± 11.7 | 67.5 ± 11.9 | 0.058 |
| Height (cm) | 160.9 ± 8.4 | 162.6 ± 9.6 | 0.376 |
| BMI (kg/m2) | 24.1 ± 3.3 | 25.5 ± 3.6 | 0.060 |
| ASA (1/2/3) | 4/29/14 | 1/32/13 | 0.465 |
| Smoking status (0/1/2) | 26/17/4 | 22/21/3 | 0.690 |
| Atrial fibrillation | 0 (0.0) | 1 (2.2) | 0.495 |
| COPD | 1 (2.1) | 1 (2.2) | 1.000 |
| CVA | 4 (8.5) | 2 (4.3) | 0.677 |
| Diabetes mellitus | 9 (19.1) | 12 (26.1) | 0.424 |
| Hypertension | 25 (53.2) | 22 (47.8) | 0.605 |
| IHD | 5 (10.6) | 6 (13.0) | 0.720 |
| Lobectomy site (1/2/3/4/5/6) | 15/4/12/9/6/1 | 16/3/8/11/7/1 | 0.778 |
| ppoFEV1 (%) | 77.4 ± 14.8 | 70.2 ± 13.4 | 0.016 |
Values are presented as mean ± SD, number only or number (%). BMI: body mass index, ASA: American Society of Anesthesiologists physical status classification, Smoking status: 0 = none; 1 = former; 2 = current, COPD: chronic obstructive pulmonary disease, CVA: cerebrovascular accident, IHD: ischemic heart disease, Lobectomy site: 1 = right upper lobe; 2 = right middle lobe; 3 = right lower lobe; 4 = left upper lobe; 5 = left lower lobe; 6 = right middle lobe and right lower lobe, right upper lobe and right middle lobe, respectively, ppoFEV1: predictive postoperative FEV1 =FEV1×(1-seg/42).